MK-677 'day 3' TikTok journeys: what the science actually says

What did @ja.iscold actually say?

Honestly? Almost nothing intelligible. The transcript from this 68,800-view TikTok is largely incoherent, possibly auto-generated from garbled audio, a non-English language being translated poorly, or significant background noise. Phrases like "he's a bad guy who's a bad guy" and "I want to ask someone to have a new sitter, before I can picture the Olympics" do not constitute health claims in any meaningful sense.

The caption frames this as a "Day 3 MK-677 real experience full journey," which tells us the video is likely a personal anecdote about early MK-677 use. But because the transcript is unintelligible, we cannot fact-check specific claims. What we can do is fact-check the implied premise: that a three-day MK-677 experience is worth documenting and following.

Does the science back this up?

MK-677, also known as ibutamoren, is a ghrelin receptor agonist that stimulates growth hormone secretion. It is not a SARM despite frequent mislabeling online. The research base is real but narrow, and three days of use tells you almost nothing about outcomes.

Most peer-reviewed trials run eight weeks minimum. Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) showed that MK-677 increased IGF-1 and growth hormone levels in older adults over 12 months, but also noted increased fasting glucose and insulin resistance in some participants. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed GH pulse amplification, but in a tightly controlled clinical setting. Neither study involved healthy young adults chasing gym gains over a weekend.

By day three, the most commonly reported effects are water retention, increased appetite, and vivid dreams, none of which indicate the compound is "working" in any clinically significant sense. IGF-1 levels take weeks to meaningfully shift. Anyone calling day three a "real experience" is documenting a placebo window at best.

What did they get wrong (or right)?

We cannot credit or discredit specific claims because the transcript does not contain them. That is itself the problem. A video with 68,800 views about an unregulated research compound, aimed at a fitness audience, should be communicating clearly. This one is not.

What the video gets right by implication: documenting a personal journey rather than claiming clinical outcomes is a less harmful format than "MK-677 gave me 10 pounds of muscle." Personal anecdotes framed as personal anecdotes carry less misinformation risk than authoritative health advice.

What it gets wrong: MK-677 is not approved by the FDA for human use outside of clinical trials. It is classified as a research compound. Presenting it casually under fitness hashtags like "gymtransformation" normalizes use of a compound that carries real risks, including elevated blood glucose, increased cortisol, and potential long-term effects on insulin sensitivity. The audience seeing this content is unlikely to know any of that.

What should you actually know?

MK-677 is not a peptide in the technical sense. It is a small-molecule ghrelin mimetic, which matters because it is orally active, unlike true peptides. It stimulates the pituitary to release growth hormone rather than supplying exogenous GH directly. That distinction is clinically relevant.

The compound has a half-life of roughly 24 hours, meaning it does accumulate with daily dosing. Side effects documented in trials include increased appetite, edema, fatigue, and elevated fasting blood glucose. Colao et al. (2004, New England Journal of Medicine) established that supraphysiologic GH states in general carry cardiovascular and metabolic risks, a caution that applies broadly to GH secretagogues.

If you are seeing MK-677 content on TikTok, the realistic picture is this: the human evidence is limited, mostly in elderly or GH-deficient populations, the compound is unregulated in most markets, and a three-day "experience" video tells you nothing about safety or efficacy. Consult a licensed clinician before considering any secretagogue.